Expression of oestrogen receptor-α splicing variants and oestrogen receptor-β in endometrium of infertile patients

Molecular Human Reproduction

Volumn 4, Issue 7, 1998, Pages 641-647

  Rey, J M ^a,b   Pujol, P ^a,b   Dechaud, H ^a   Edouard, E ^a   Hedon, B ^a   Maudelonde, T ^a,b  

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

^b INSERM   (France)

Author keywords

Endometrium; Infertility; Oestrogen receptors; Splicing variants

Indexed keywords

ESTROGEN RECEPTOR; RECEPTOR SUBTYPE;

ARTICLE; ENDOMETRIUM; EXON; FEMALE; FEMALE INFERTILITY; FOLLICULAR PHASE; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UTERUS BIOPSY;

ALTERNATIVE SPLICING; ANIMALS; ENDOMETRIUM; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; EXONS; FEMALE; HUMANS; INFERTILITY, FEMALE; MICE; MICE, TRANSGENIC; POLYMERASE CHAIN REACTION; PREGNANCY; RECEPTORS, ESTROGEN; RNA, MESSENGER; SEQUENCE ANALYSIS, DNA;

MUS MUSCULUS;

EID: 0031824384     PISSN: 13609947     EISSN: None     Source Type: Journal    
DOI: 10.1093/molehr/4.7.641     Document Type: Article

References (37)

1. Ambrosino, C., Cicatiello, L., Cobiellis, G. et al. (1993) Functional antagonism between the estrogen receptor and Fos on the regulation of c-fos protooncogene transcription. Mol. Endocrinol., 7, 1472-1483.
2. Brandenberger, A.W., Tee, M.K., Lee, J.Y. et al. (1997) Tissue distribution of estrogen receptors alpha (ER-alpha) and beta (ER-beta) mRNA in the midgestational fetus. J. Clin. Endocr. Metab., 82, 3509-3512.
3. Chaidarun, S.S., Klibanski, A., and Alexander, J M. (1997) Tumor-specific expression of alternatively spliced estrogen receptor messenger ribonucleic acid variants in human pituitary adenomas. J. Clin. Endocr. Metab., 82, 1058-1065.
4. Ciocca, D.R. and Vargas Roig, L.M (1995) Estrogen receptor in human non target tissues: biological and clinical implications. Endocr. Rev., 16, 35-62.
5. Collins, J.A. and Crosignani, P.G. (1992) Unexplained infertility: a review of diagnosis, prognosis, treatment efficacy and management. Int. J. Gynecol. Obstet., 39, 267-275.
6. Couse, J.F., Curtis, S.W., Washburn, T.F. et al (1995) Analysis of transcription and estrogen insensitivity in the female mouse after disruption of the estrogen receptor gene. Mol. Endocrinol., 9, 1441-1454.
7. Dean, D.M. and Sanders, M.M. (1996) Ten years after: reclassification of steroid-responsive genes. Mol. Endocrinol., 10, 1489-1495.
8. Desai, A J., Luqmani, Y.A. and Ali, S. (1997) Presence of exon 5-deleted oestrogen receptor in human breast cancer: functional analysis and clinical significance. Br. J. Cancer, 75, 1173-1184.
9. Dowset, M., Daffada, A., Chan, C M.W. et al. (1997) Oestrogen receptor mutants and variants in breast cancer. Eur. J. Cancer, 33, 1177-1183.
10. Fujimoto, J., Ichigo, S., Hirose, R. et al. (1997) Expression of estrogen receptor wild type and exon 5 splicing variant mRNAs in normal and endometriotic endometria during the menstrua] cycle. Gynecol. Endocrinol., 11, 11-16.
11. Fuqua, S.A., Fitzgerald, S.D., Allred, D.L. et al. (1992) Inhibition of estrogen receptor action by a naturally occuring variant in human breast tumors Cancer Res., 52, 483-486.
12. Hirata, S., Yamada-Mouri, N., Nara, M. et al. (1995) The presence of alternatively splice-estrogen mRNA variants in normal human uterine endometrium and endometrial cancer. Endocr. J., 42, 289-293.
13. Hu, C., Hyder, S.M., Needleman, D.S. et al. (1996) Expression of estrogen receptor variants in normal and neoplastic human uterus. Mol. Cell Endocrinol., 118, 173-179.
14. Jacq, X., Brou, C., Lutz, Y. et al. (1994) Human TAFII30 is present in a distinct TFIID complex and is required for transcriptional activation by the estrogen receptor. Cell, 79, 107-117.
15. Jones, R.K., Bulmer, J.N and Searle, R F. (1995) Immunohistochemical characterization of proliferation, oestrogen receptor and progesterone receptor expression in endometriosis: comparison of eutopic and ectopic endometrium with normal cycling endometrium. Hum. Reprod., 10, 3272-3279.
16. Koehorst, S.G.A., Cox, J.J., Donker, G.H. et al. (1994) Functional analysis of an alternatively spliced estrogen receptor lacking exon 4 isolated from MCF-7 breast cancer cells and meningioma tissue. Mol. Cell Endocrinol , 101, 237-245.
17. Koehorst, S G.A., Jacobs, H.M., Thussen, J H.H. et al. (1993) Wild type and alternatively spliced estrogen receptor messenger RNA in human meningioma tissue and MCF-7 breast cancer cells. J. Steroid Biochem., 45, 227-233.
18. Kuiper, G., Enmark, E., Pelto-Huikko, M. et al. (1996) Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. USA, 93, 5925-5930.
19. Leygue, E.R., Huang, A , Murphy, L.C. et al. (1996a) Prevalence of estrogen receptor variant messenger RNAs in human breast cancer. Cancer Res., 56, 4324-4327.
20. Leygue, E.R., Watson, P.H. and Murphy, L.C. (1996b) Estrogen receptor variants in normal human mammary tissues. J. Natl. Cancer Inst., 88, 284-290.
21. R -1 compared to the parental MCF 7 cell line. Mol. Cell Endocrinol , 109, 197-207.
22. Metzger, D A., Szpak, C.A. and Haney, A.F. (1993) Histologic features associated with hormonal responsiveness of ectopic endometrium. Fertil. Steril., 59, 83-88.
23. Miksicek, R.J., Lei, Y. and Wang, Y. (1993) Exon skipping gives rise to alternatively spliced forms of the estrogen receptor in breast tumor cells. Breast Cancer Res. Tr., 26, 163-174.
24. Mosselman, S., Polman, J., and Dijkema, R. (1996) ERβ: identification and characterization of a novel human estrogen receptor. FEBS Lett., 392, 49-53.
25. Pennisi, E. (1997) Differing roles found for estrogen's two receptors. Science, 277, 1439.
26. Pettersson, K., Gradien, K., Kuiper, G.G.J.M. et al. (1997) Mouse estrogen receptor β forms response element-binding heterodimers with estrogen receptor α. Mol. Endocrinol., 11, 1486-1496.
27. Pfeffer, U., Fecarotta, E , Castagnetta, L. et al. (1993) Estrogen receptor variant messenger RNA lacking exon 4 in estrogen-responsive human breast cancer cell lines. Cancer Res., 53, 741-743.
28. Pfeffer, U., Fecarotta, E., Arena, G. et al. (1996) Alternative splicing of the estrogen receptor primary transcript normally occurs in estrogen receptor positive tissues and cell lines. J. Steroid Biochem., 56, 99-105.
29. Planas-Silva, M.D. and Weinberg, R.A. (1997) Estrogen-dependent cyclin E-cdk2 activation through p21 redistribution. Mol. Cell Biol., 17, 4059-4069.
30. Pongtikitmongkol, M., Green, S. and Chambon P. (1988) Genomic organization of the human oestrogen receptor gene. EMBO J., 7, 3385-3388.
31. Prall, O.W.J , Sarcevic, B , Musgrove, E.A. et al. (1997) Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cylin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2. J. Biol. Chem., 272, 10882-10894.
32. Rice, W., Jazaeri, A.A. and Shupnic, M.A. (1997) Estrogen receptor mRNA splice variants in pre-and post-menopausal human endometrium and endometrial carcinoma. Gynecol. Oncol., 65, 149-157.
33. Ruiz-Velasco, V. (1997) Current concepts on the correlation of endometriosis and sterility. An. R. Acad. Nac. Med., 114, 419-441.
34. Salmi, A., Ammälä, M. and Rutanen, E.M. (1996) Proto-oncogenes c-jun and c-fos are down-regulated in human endometrium during pregnancy: relationship to oestrogen receptor status. Mol. Hum. Reprod., 2, 979-984.
35. Severino, M.F., Murray, M.J., Brandon, D.D. et al. (1996) Rapid loss of oestrogen and progesterone receptors in human leiomyoma and myometrial explant cultures. Mol. Hum. Reprod., 2, 823-828.
36. Shiozawa, T., Li, S.F., Nakayama, K. et al. (1996) Relationship between the expression of cyclins/cyclin-dependent kinases and sex-steroid receptors/ Ki67 in normal human endometrial glands and stroma during the menstrual cycle. Mol. Hum. Reprod., 2, 745-752.
37. Wang, Y. and Miksicek, R.J. (1991) Identification of a dominant negative form of the human estrogen receptor. Mol. Endocrinol., 5, 1707-1715.